Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The 12th World Congress on Controversies in Multiple Myeloma (COMy) took place on May 14-17, 2026, in Paris, France. Leading researchers congregated at this meeting to discuss the latest advances in the scientific understanding and clinical treatment of multiple myeloma.
View all videos

COMy 2026

The 12th World Congress on Controversies in Multiple Myeloma
14–17 May 2026 | Paris, France

COMy 2026

The 12th World Congress on Controversies in Multiple Myeloma
14–17 May 2026 | Paris, France
The 12th World Congress on Controversies in Multiple Myeloma (COMy) took place on May 14-17, 2026, in Paris, France. Leading researchers congregated at this meeting to discuss the latest advances in the scientific understanding and clinical treatment of multiple myeloma.
View all videos

Latest videos

View all
3:37
Updated IMWG myeloma response criteria: insights and practical challenges
Heinz Ludwig • 14 May 2026
2:13
Temporal trends in progression risk in smoldering myeloma: insights into a review
Heinz Ludwig • 14 May 2026
1:52
Bispecifics in myeloma: insights and challenges in a community setting
Heinz Ludwig • 14 May 2026
2:38
Insights into functional high-risk myeloma and how to adapt treatment for these patients
Martin Kaiser • 14 May 2026

Treatment updates

View all
1:52
Bispecifics in myeloma: insights and challenges in a community setting
Heinz Ludwig • 14 May 2026
2:38
Insights into functional high-risk myeloma and how to adapt treatment for these patients
Martin Kaiser • 14 May 2026

Immunotherapy

View all
1:52
Bispecifics in myeloma: insights and challenges in a community setting
Heinz Ludwig • 14 May 2026
2:01
The current status of bispecifics and CAR-T in Waldenström’s macroglobulinemia
Steven Treon • 14 May 2026
The content of VJHemOnc is intended for healthcare professionals